Cumberland Pharmaceuticals Inc
A specialty biopharmaceutical company that develops and sells branded prescription medicines for hospitals, including Acetadote, an injection used to treat acetaminophen (Tylenol) poisoning, and Caldolor, an intravenous ibuprofen for pain and fever. Founded in 1999 in Nashville, Tennessee, it takes its name from the Cumberland River that runs through the city. Its Acetadote was the first injectable product approved in the United States for treating acetaminophen overdose.
Bought 13
Granted 5.8K · Bought 68
Granted 1.8K
Granted 1.8K · Bought 13
Granted 1.8K · Bought 6
Granted 1.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Kazimi A JChairman and CEO, Director, 10% owner · 87 transactions | -0.1% | 5.70M | — | 13 | — |
| Krogulski KennethDirector · 88 transactions | +4.4% | 302.3K | 5.8K | 68 | — |
| Galante Joseph CDirector · 1 transaction | +2.9% | 63.7K | 1.8K | — | — |
| Jones JamesDirector · 87 transactions | +6.7% | 46.9K | 1.8K | 13 | — |
| Young CarolineDirector · 87 transactions | +6.6% | 35.1K | 1.8K | 6 | — |
| Brown Martin S JRDirector · 1 transaction | +21.2% | 10.3K | 1.8K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last year: +100 shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.